Which laboratory test is definitive for diagnosing myasthenia gravis?
সমাধান
সঠিক উত্তর: Option A
- The definitive laboratory test for diagnosing myasthenia gravis is the Anti-acetylcholine receptor (AChR) antibody assay.
- This test detects the presence of circulating antibodies directed against the acetylcholine receptors at the neuromuscular junction, which are responsible for the characteristic muscle weakness seen in myasthenia gravis.
Key points to understand include:
- Anti-acetylcholine receptor antibody assay: More than 80-90% of patients with generalized myasthenia gravis have detectable AChR antibodies. The presence of these antibodies is highly specific for the disease, making this test the most definitive diagnostic tool.
- Serum creatine kinase level: This test measures muscle damage but is typically normal in myasthenia gravis, as it is not a primary muscle disease.
- Electromyography (EMG) with nerve conduction studies: While repetitive nerve stimulation and single-fiber EMG can support the diagnosis by demonstrating a defect in neuromuscular transmission, these tests are supportive rather than definitive.
- Muscle biopsy: This is generally not used for diagnosing myasthenia gravis, as it does not provide specific diagnostic information related to the autoimmune mechanism of the disease.
In summary, the Anti-acetylcholine receptor antibody assay is the most specific and definitive diagnostic test for myasthenia gravis and is essential for confirming the diagnosis.
Reference: Harrison’s Principles of Internal Medicine, 20th Edition, Volume 2, Chapter 286: Disorders of the Neuromuscular Junction and Muscle
- This test detects the presence of circulating antibodies directed against the acetylcholine receptors at the neuromuscular junction, which are responsible for the characteristic muscle weakness seen in myasthenia gravis.
Key points to understand include:
- Anti-acetylcholine receptor antibody assay: More than 80-90% of patients with generalized myasthenia gravis have detectable AChR antibodies. The presence of these antibodies is highly specific for the disease, making this test the most definitive diagnostic tool.
- Serum creatine kinase level: This test measures muscle damage but is typically normal in myasthenia gravis, as it is not a primary muscle disease.
- Electromyography (EMG) with nerve conduction studies: While repetitive nerve stimulation and single-fiber EMG can support the diagnosis by demonstrating a defect in neuromuscular transmission, these tests are supportive rather than definitive.
- Muscle biopsy: This is generally not used for diagnosing myasthenia gravis, as it does not provide specific diagnostic information related to the autoimmune mechanism of the disease.
In summary, the Anti-acetylcholine receptor antibody assay is the most specific and definitive diagnostic test for myasthenia gravis and is essential for confirming the diagnosis.
Reference: Harrison’s Principles of Internal Medicine, 20th Edition, Volume 2, Chapter 286: Disorders of the Neuromuscular Junction and Muscle